在没有中度至重度阻塞性睡眠呼吸暂停症的个体中,用于治疗症状性打和空气流量限制的阿托莫克西丁加氧丁宁
Nicole Calianese1, Lauren B Hess1, Daniel Vena1
1Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
一种新的药物组合显著降低了打的声音和改善了习惯性打的个体的空气流限制. 较低剂量也改善了床上伴侣的结果,为更好的睡眠质量提供了希望.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 睡眠呼吸障碍扩展到除了呼吸暂停-呼吸暂停指数之外.
- 打和空气流量限制显著影响患者和伴侣的睡眠质量.
- 目前用于打的治疗方法往往不能全面解决这些问题.
研究的目的:
- 评估一种结合的诺亚上腺和抗肌糖药物干预措施在减少打的声音和空气流量限制方面的有效性.
- 评估这种药理干预对患者和床上伴侣报告的结果的影响.
- 为了确定症状性打治疗的最佳剂量.
主要方法:
- 进行了一项随机,安慰剂控制,双盲交叉研究.
- 习惯性大声打的参与者接受了全剂和半剂量的阿托莫克西丁加上氧丁宁.
- 用气管声音记录的多睡眠学测量了打的声音和空气流量限制.
主要成果:
- 全剂量和半剂量的阿托莫克西加氧丁宁显著减少了大约三分之二的打声音.
- 流量限制的严重程度也在两剂剂量有意义地降低.
- 半剂量治疗方案显示,床上伴侣报告的结果有所改善.
结论:
- 阿托莫克西丁加上氧丁宁有效改善了习惯性打的个体的打和空气流量限制.
- 半剂量疗法可能为床上伴侣提供额外的好处.
- 这种组合疗法为治疗症状性打提供了一个有希望的方法.
更多相关视频
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
相关概念视频
Sleep Apnea
The condition is more prevalent among...
Cholinergic Antagonists: Pharmacokinetics
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
